申请人:REGENTS OF THE UNIVERSITY OF MINNESOTA
公开号:US20180085306A1
公开(公告)日:2018-03-29
Certain embodiments of the invention provide a formulation suitable for nasal administration comprising water, a prodrug of a therapeutic agent, and an enzyme that is suitable for intranasal conversion of the prodrug to the therapeutic agent, as well as methods of use thereof.